Additionally, NK cells equipped with synthetic receptors targeting stromal components like FAP or integrins may selectively disrupt the tumor stroma while maintaining anti-tumor activity, offering a promising strategy for tackling the complex TME of biliary malignancies (92). The gene discussed is FAP; the disease is neoplasm.